Surviving glioblastoma for more than 5 years: The patient's perspective

Neurology

Volumn 66, Issue 2, 2006, Pages 239-242

  Steinbach, J P ^a,c   Blaicher, H P ^a   Herrlinger, U ^a   Wick, W ^a   Nangele T ^b   Meyermann, R ^b   Tatagiba, M ^b   Bamberg, M ^b   Dichgans, J ^a   Karnath, H O ^a   Weller, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NIMUSTINE; NITROSOUREA DERIVATIVE; TENIPOSIDE;

ADULT; ANXIETY; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COGNITIVE DEFECT; DEPRESSION; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL STATUS; WORK CAPACITY; BRAIN TUMOR; DAILY LIFE ACTIVITY; HUMAN RELATION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; SURVIVOR; TIME; WORK;

ACTIVITIES OF DAILY LIVING; ADULT; ANXIETY; BRAIN NEOPLASMS; COGNITION DISORDERS; DEPRESSION; FEMALE; GLIOBLASTOMA; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SURVIVORS; TIME FACTORS; WORK;

EID: 33644910465     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000194221.89948.a0     Document Type: Article

References (10)

1. Scott JN, Rewcastle NB, Brasher PM, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999;46:183-188.
2. McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 2003;98:1745-1748.
3. Burton EC, Lamborn KR, Feuerstein BG, et al. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 2002;62:6205-6210.
4. Metcalfe SE, Grant R. Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 2001;CD002034.
5. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996.
6. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994;80:247-253.
7. Taylor BV, Buckner JC, Cascino TL, et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 1998;16:2195-2201.
8. Schmidinger M, Linzmayer L, Becherer A, et al. Psychometric and quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol 2003;63:55-61.
9. Neuro-Oncology Working Group of the German Cancer Society. NeuroOncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 2003;21:3276-3284.
10. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.